Adjuvant chemotherapy in endometrial cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s00280-019-04027-6.pdf
Reference77 articles.
1. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30
2. Lewin SN, Herzog TJ, BarrenaMedel NI, Deutsch I, Burke WM, Sun X et al (2010) Comparative performance of the 2009 international federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol 116(5):1141–1149
3. Kong A, Johson N, Kitchener HC, Lawrie TA (2012) Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst 104(21):1625–1634
4. Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J et al (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol 27(1):16–41
5. Sasada S, Yunokawa M, Takehara Y, Ishikawa M, Ikeda S, Kato T et al (2018) Baseline risk of recurrence in stage I–II endometrial carcinoma. J Gynecol Oncol. 29(1):e9
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endometrial Cancer: 2023 Revised FIGO Staging System and the Role of Imaging;Cancers;2024-05-14
2. Hypofractionated Radiotherapy in Gynecologic Malignancies—A Peek into the Upcoming Evidence;Cancers;2024-01-15
3. The use of adjuvant chemotherapy combined with concurrent chemoradiotherapy enhances survival rates in cases of locally advanced nasopharyngeal carcinoma;American Journal of Cancer Research;2024
4. Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT/FOXO1 Pathway;Anti-Cancer Agents in Medicinal Chemistry;2023-11
5. Comparison of frozen section accuracy with final pathology results in early clinical stage of endometrioid type endometrial cancer;The European Research Journal;2023-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3